These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 25420107)

  • 21. Expression of cysteine-rich 61 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma.
    Xie JJ; Xu LY; Wu ZY; Li LY; Xu XE; Wu JY; Huang Q; Li EM
    Eur J Surg Oncol; 2011 Aug; 37(8):669-74. PubMed ID: 21664098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased Expression of PDHE1α Predicts Worse Clinical Outcome in Esophageal Squamous Cell Carcinoma.
    Zhong Y; Huang R; Li X; Xu R; Zhou F; Wang J; Fan H; Goscinski M; Zhang M; Wen JG; Nesland JM; Suo Z
    Anticancer Res; 2015 Oct; 35(10):5533-8. PubMed ID: 26408721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do tumor grade and location affect survival in esophageal squamous cell carcinoma? Survival analysis of 302 cases of pT3N0M0 esophageal squamous cell carcinoma.
    Situ D; Wei W; Lin P; Long H; Zhang L; Fu J; Rong T; Ma G
    Ann Surg Oncol; 2013 Feb; 20(2):580-5. PubMed ID: 23015029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sirtuin-3 (SIRT3) expression is associated with overall survival in esophageal cancer.
    Zhao Y; Yang H; Wang X; Zhang R; Wang C; Guo Z
    Ann Diagn Pathol; 2013 Dec; 17(6):483-5. PubMed ID: 23871415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of lymph node metastases and lymph node ratio in esophageal squamous cell carcinoma.
    Liu YP; Ma L; Wang SJ; Chen YN; Wu GX; Han M; Wang XL
    Eur J Surg Oncol; 2010 Feb; 36(2):155-9. PubMed ID: 19854606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus.
    Shamma A; Yamamoto H; Doki Y; Okami J; Kondo M; Fujiwara Y; Yano M; Inoue M; Matsuura N; Shiozaki H; Monden M
    Clin Cancer Res; 2000 Apr; 6(4):1229-38. PubMed ID: 10778945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of Y-box-binding protein-1 is associated with poor survival in resectable esophageal squamous cell carcinoma.
    Li Y; Wen ZS; Yang HX; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
    Ann Surg Oncol; 2011 Nov; 18(12):3370-6. PubMed ID: 21630125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.
    Zhou S; Yang B; Zhao Y; Xu S; Zhang H; Li Z
    J Surg Res; 2014 Dec; 192(2):515-20. PubMed ID: 25218280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
    Ando T; Ishiguro H; Kimura M; Mitsui A; Mori Y; Sugito N; Tomoda K; Mori R; Harada K; Katada T; Ogawa R; Fujii Y; Kuwabara Y
    Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of serum matrix metalloproteinase-13 levels in patients with esophageal squamous cell carcinoma (ESCC).
    Jiao XL; Chen D; Wang JG; Zhang KJ
    Eur Rev Med Pharmacol Sci; 2014; 18(4):509-15. PubMed ID: 24610617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
    Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
    J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of pituitary tumor transforming gene (PTTG) is associated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
    Zhang J; Yang Y; Chen L; Zheng D; Ma J
    Acta Histochem; 2014 Apr; 116(3):435-9. PubMed ID: 24176776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclophilin A expression and its prognostic significance in lung adenocarcinoma.
    Nakano N; Sakashita S; Matsuoka R; Murata Y; Shiba-Ishii A; Kobayashi N; Sato Y; Noguchi M
    Pathol Int; 2017 Nov; 67(11):555-563. PubMed ID: 29027312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of CyclophilinA/CD147 Axis Induces Cell Apoptosis and Inhibits Glioma Aggressiveness.
    Xu S; Hu C; Xiao Z; Luo C; Liu Z
    Biomed Res Int; 2020; 2020():7035847. PubMed ID: 32775435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ubiquitin-specific protease 4 improves the prognosis of the patients in esophageal cancer.
    Yao R; Pu J; Fan R; Zhu W; Ding X; Shen X; Zhang T
    Cancer Biomark; 2017 Sep; 20(3):317-323. PubMed ID: 28946564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surrogate Prognostic Biomarkers in OSCC: The Paradigm of PA28γ Overexpression.
    Kontos CK
    EBioMedicine; 2015 Aug; 2(8):784-5. PubMed ID: 26425675
    [No Abstract]   [Full Text] [Related]  

  • 37. [Preparation and application of mouse monoclonal antibodies against human cyclophilin A (CypA)].
    Qiao L; Hong X; Li S; He C; Gao S; Wang H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Aug; 34(8):746-751. PubMed ID: 30384873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of altered expression and localization of cyclophilin A on differentiation of p19 embryonic carcinoma cells.
    Chiu R; Rey O; Zheng JQ; Twiss JL; Song J; Pang S; Yokoyama KK
    Cell Mol Neurobiol; 2003 Dec; 23(6):929-43. PubMed ID: 14964780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resected esophageal squamous cell carcinoma.
    Rodríguez-Sanjuán JC; Val-Bernal F
    World J Surg; 1996 Jan; 20(1):115-6. PubMed ID: 8588402
    [No Abstract]   [Full Text] [Related]  

  • 40. [Progress of CypA and lung cancer-related research].
    Qian Z; Yue W; Li B
    Zhongguo Fei Ai Za Zhi; 2010 Aug; 13(8):827-31. PubMed ID: 20704827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.